Beckman Coulter Receives FDA Breakthrough Device Designation for Alzheimer’s Disease Blood Test

Beckman Coulter Diagnostics, a global leader in clinical diagnostics, today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Beckman Coulter's Access p‑Tau217/B-Amyloid 1-42 plasma ratio. This blood test is designed to aid healthcare providers identify patients with amyloid pathology associated with Alzheimer's disease. https://mma.prnewswire.com/media/2607519/pTau217_2_1080x1080.jpg “We are honored to receive […]

Neurocrine Biosciences Announces Initiation of Phase 3 Registrational Program for Osavampator as an Adjunctive Therapy for the Treatment of Major Depressive Disorder in Adults

Neurocrine Biosciences, Inc.(Nasdaq: NBIX) today announced the initiation of a Phase 3 registrational study to evaluate the efficacy, safety and tolerability of osavampator (formerly NBI-1065845), an investigational drug under development as an adjunctive treatment to antidepressants for major depressive disorder (MDD). Positive topline data for the Phase 2 SAVITRI™ study of osavampator in adult subjects

The RCLCO Foundation recognizes Community Corporation of Santa Monica with 2025 Affordable Housing Leadership Award

Community Corp. provides affordable rental units to 2,000 low-income households in Santa Monica, California (almost 5% of the City's total households), with more being built to expand affordable housing in one of the most expensive areas in the US and where destruction from recent fires will exacerbate the housing shortage. The RCLCO Foundation and RCLCO,

PharmaScroll: Redefining Pharmaceutical Market Analytics and Insights

PharmaScroll, a premier market research and business analytics firm, continues to set the benchmark for excellence in supporting the global life sciences and healthcare organizations. Renowned for its innovative tech-based solutions and in-depth functional expertise, PharmaScroll has become a trusted partner for businesses navigating the complexities in offering care to the patients. https://mma.prnewswire.com/media/2328621/PharmaScroll_Logo.jpg “We are

Cooper Standard to Discuss Fourth Quarter and Full Year 2024 Results, Provides Details for Management Conference Call

Cooper-Standard Holdings Inc. (NYSE: CPS) expects to release its financial results for the fourth quarter and full year 2024 on Thursday, February 13 after market close. The Company's earnings results will be posted to the Cooper Standard website (https://ir.cooperstandard.com/) once released. https://mma.prnewswire.com/media/2044542/Cooper_Standard_Logo_5_3_23_Logo.jpg Cooper Standard will host a conference call on Friday, February 14 at 9

Cincinnati Children’s names Daniel Ostlie, MD, as next surgeon in chief and senior vice president

He will oversee department that performs over 40,000 operations annually Cincinnati Children's has named Daniel Ostlie, MD, as the health system's next surgeon in chief and senior vice president. https://mma.prnewswire.com/media/2607731/Dr__Daniel_Ostlie.jpg Dr. Daniel Ostlie will be a member of the 11-person Executive Team at Cincinnati Children's. He will join Cincinnati Children's by June 1 and oversee

Elevated Practice Solutions (EPS) to Support Greater New York Anesthesia Services

A joint venture between Mount Sinai Ambulatory Ventures and U.S. Anesthesia Partners will utilize EPS' customized offerings – including revenue cycle management, quality reporting, provider scheduling, credentialing and more – to support new anesthesia practice serving patients in greater New York City. A joint venture between Mount Sinai Ambulatory Ventures, Inc. and U.S. Anesthesia Partners,

FinOps Foundation Announces Oracle as a Premier Member

Foundation Growth Reflects Value of FinOps Adoption The FinOps Foundation, a part of the Linux Foundation's non-profit technology consortium focusing on advancing the people and practice of FinOps, announced today that Oracle has upgraded to Premier Member. https://mma.prnewswire.com/media/1869192/FinOps_Foundation_Logo.jpg The FinOps Foundation serves as a global community for those who manage the value of, promoting collaboration,

Embotech Collaborates with Outsight and Hesai to Power Technology for Automated Vehicle Marshalling (AVM) Systems

Hesai Technology (Nasdaq: HSAI), Outsight, and Embotech AG announce a strategic collaboration to deliver cutting-edge lidar technology and perception software for Embotech's AVM technology deployed in BMW facilities and known internally at BMW as Automated Driving In-Plant (AFW). This collaboration brings together industry leaders in autonomous driving solutions and sensing technology. Embotech is the system

Meridian Health Plan of Illinois Awards $528,000 in Health Happens Here Grants™ in the Second Half of 2024

More than $1.3 million has been given in 2024 to organizations to promotehealth equity in communities throughout Illinois Meridian Health Plan of Illinois, Inc.(Meridian),a provider of government-sponsored managed care services to families, children, seniors, and individuals with complex medical needs and a Centene company, today announced it has awarded $528,916 in Health Happens HereGrants™ to

Scroll to Top